Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20
Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase
Paris, July 1st, 2021 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases,
Towards a new standard for device indication: Implantation for temporary or permanent use • Easy removal with a beating heart
by Jean-Alexandre Kaminisky, 2021-03-18 Karista invests in MyPL increasing its financing to €1.8m & accelerating its development Paris – France, March
by Jean-Alexandre Kaminisky, 2021-03-16 MyPL wins €1.1 Million European Union grant as part of Horizon Europe 2020 GerOnTe[1] project out of a
Introductions : Acticor, 20 ME à lever
Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20
Paris, July 22, 2021 – Acticor Biotech, a clinical stage biotechnology company developing an innovative drug for the acute phase
Acticor Biotech Announces the Completion of Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study
Paris, July 1st, 2021 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases,
Latest Insights
by Jean-Alexandre Kaminisky, 2021-03-16 MyPL wins €1.1 Million European Union grant as part of Horizon Europe 2020 GerOnTe[1] project out of a
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA,CANADA, AUSTRALIA AND JAPAN The first connected all-in-one Diabetes Management System Paris,
Paris, October 16, 2018 – Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including
A major step and a critical milestone achieved prior to First In Human clinical trials FineHeart’s TET is a system
Bouriser.com – Depuis vendredi, l’offre de titres Acticor est lancée dans le cadre de son augmentation de capital d’environ 20